A flurry of activity surrounds the Netherlands Centre for One Health (NCOH) at the moment.
The documents that will secure the National Institute for Public Health and the Environment (RIVM) as an NCOH Associate Partner are currently making the rounds. This will be the first step in strengthening the collaboration with the RIVM in a variety of areas. The greatest challenge, of course, lies in putting such a partnership into practice. This applies to all NCOH Partners and is something we are trying to achieve through shaping our research agenda.
One element is the NCOH call for PhD candidates, which will be sent out in the coming weeks. We will be asking all NCOH Partners to assign PhD candidates to broader research lines. The idea is that we will invest as heavily as possible in collaborative projects to bring together multiple PhD candidates. In doing so, we will share our vision with the outside world and show how we intend to tackle today’s One Health challenges.
In addition, external opportunities are emerging that will provide added possibilities to communicate our vision in the coming period. For instance, we are currently working toward the first steps in setting up a One Health research programme with the Topsector Life Sciences & Health. This programme is likely to start in 2019. We hope to be able to share further details of this in the not-too-distant future.
In short: we are seeing interesting and exciting developments that offer the potential not only to reap the benefits of our own efforts, but also to further strengthen the research collaborations between NCOH Partners.
Dick Heederik, chair NCOH Executive Board
The Netherlands Centre for One Health (NCOH) was allocated a budget of two million euro Public-Private Partnership (PPP) Allowance to organise and realise their first PPP call. This call involves strategic partnerships under the Knowledge and Innovation Agenda of Top Sector Life Sciences & Health (LSH): One Health call.
The number of bacteria that are resistant to antibiotics is increasing globally. In the Netherlands this number remains fairly stable and is lower than in many other countries. Nevertheless, there is still cause for concern and caution. This is evident from the annual report NethMap/MARAN 2019 in which various organisations jointly present data on antibiotic...
A malaria vaccine, based on genetically-manipulated malaria parasites. That is the goal of Meta Roestenberg (LUMC) and Robert Sauerwein (Radboudumc). More than ten years of collaboration is nearing completion. But the vaccine could be even better…
The second edition of the NCOH Magazine has been published at the Annual Scientific Meeting at Radboudumc 17 may. Here is your chance to look at the digital version.